Broad Portfolio of Antibodies Designed for Big Research Challenges

11 December 2017

At Neuroscience 2017, Patrick Schneider, Head of R&D, Technology and Business Development at MilliporeSigma, discusses the broad product portfolio of antibodies, small molecules, agonists and antagonists made available by MilliporeSigma to solve the challenges of neuroscience. He goes on to further explain how each antibody at MilliporeSigma goes through a robust validation process.